EN
CN EN

Enzalutamide Tablets

Strength：40mg, 80mg
Indication：castration-resistant prostate cancer (CRPC); metastatic castration-sensitive prostate cancer (mCSPC).

About
Us
Who we are
Milestone
Corporate culture
Corporate social responsibility (CSR)
Press releases
Sustainability
& Compliance
Sustainability and Compliance
Quality system
EHS
Suppy Security
R&D,Science
Innovation
Innovation and IP Security
R&D Center
Our Science
Our Pipeline
Tech Platforms
Product
& Service
API
FDF
CRO&CDMO
Manufacturing
Sites
Facilities
Investor
Relations
Secretary's Mailbox
CompanyProfile
EquityStructure
CompanyAnnouncement
Contact Us
Job openings
Career Opportunity
Contact us
Follow Aoruite WeChat official account
版权所有 奥锐特药业股份有限公司 Copyright © 2020 AURISCO.All Rights Reserved 浙ICP备17058154号-1 Legal Notice
Enterprise mailbox